Rare diseases
Investigational molecules
Locations
Back to Romania37 clinical trials in Satu Mare, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
RomaniaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
RomaniaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
RomaniaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
RomaniaRomaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
RomaniaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
RomaniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
RomaniaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
RomaniaA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
RomaniaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart failure prevention and treatment of atrial fibrillation. Research includes evaluation of new combination therapies and interventions for reducing cardiovascular events.
Advanced trials examining novel therapeutic approaches for cardiovascular disease management and prevention.
Comprehensive research into Type 2 Diabetes and obesity treatments. Studies evaluate new medications for glycemic control and weight management.
Multiple therapeutic approaches being tested to improve patient outcomes in metabolic conditions.
Groundbreaking studies in non-alcoholic steatohepatitis (NASH) treatment. Trials focus on innovative therapies to improve liver health and prevent disease progression.
Advanced research aimed at developing effective treatments for chronic liver conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
